DK0882726T3 - Carbazolcarboxamider som 5-HT1F-agonister - Google Patents

Carbazolcarboxamider som 5-HT1F-agonister

Info

Publication number
DK0882726T3
DK0882726T3 DK98304343T DK98304343T DK0882726T3 DK 0882726 T3 DK0882726 T3 DK 0882726T3 DK 98304343 T DK98304343 T DK 98304343T DK 98304343 T DK98304343 T DK 98304343T DK 0882726 T3 DK0882726 T3 DK 0882726T3
Authority
DK
Denmark
Prior art keywords
carboxamides
carbazole
ht1f agonists
ht1f
agonists
Prior art date
Application number
DK98304343T
Other languages
Danish (da)
English (en)
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0882726T3 publication Critical patent/DK0882726T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
DK98304343T 1997-06-04 1998-06-02 Carbazolcarboxamider som 5-HT1F-agonister DK0882726T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4858497P 1997-06-04 1997-06-04

Publications (1)

Publication Number Publication Date
DK0882726T3 true DK0882726T3 (da) 2003-09-22

Family

ID=21955349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98304343T DK0882726T3 (da) 1997-06-04 1998-06-02 Carbazolcarboxamider som 5-HT1F-agonister

Country Status (21)

Country Link
EP (1) EP0882726B1 (id)
JP (1) JP2002502419A (id)
KR (1) KR20010013409A (id)
CN (1) CN1259049A (id)
AT (1) ATE240953T1 (id)
AU (1) AU729786B2 (id)
BR (1) BR9810610A (id)
CA (1) CA2291624A1 (id)
DE (1) DE69814735T2 (id)
DK (1) DK0882726T3 (id)
EA (1) EA001718B1 (id)
ES (1) ES2199410T3 (id)
HU (1) HUP0004142A3 (id)
ID (1) ID23053A (id)
IL (1) IL133279A0 (id)
NO (1) NO995963D0 (id)
NZ (1) NZ501569A (id)
PL (1) PL337221A1 (id)
PT (1) PT882726E (id)
TR (1) TR199903014T2 (id)
WO (1) WO1998055115A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034266A1 (en) * 1998-12-11 2000-06-15 Eli Lilly And Company Indole derivatives and their use as 5-ht1f agonists
AU3840000A (en) 1999-04-20 2000-11-02 Meiji Seika Kaisha Ltd. Tricyclic compounds
WO2001010381A2 (en) * 1999-08-04 2001-02-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
JP2003506387A (ja) 1999-08-04 2003-02-18 アイカゲン インコーポレイテッド カリウムチャンネルオープナーとしてのベンズアニリド
US6495550B2 (en) 1999-08-04 2002-12-17 Icagen, Inc. Pyridine-substituted benzanilides as potassium ion channel openers
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
JP2006523692A (ja) 2003-04-18 2006-10-19 イーライ リリー アンド カンパニー 5−ht1f作用薬としての(ピペリジニルオキシ)フェニル、(ピペリジニルオキシ)ピリジニル、(ピペリジニルスルファニル)フェニル、および(ピペリジニルスルファニル)ピリジニル化合物
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
CA2549007A1 (en) * 2003-12-17 2005-07-07 Eli Lilly And Company Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
KR20080044273A (ko) 2005-08-08 2008-05-20 아스텔라스세이야쿠 가부시키가이샤 아실구아니딘 유도체 또는 그의 염
CN101627013A (zh) * 2007-02-07 2010-01-13 安斯泰来制药有限公司 酰基胍衍生物
KR101444572B1 (ko) * 2010-03-22 2014-09-24 액테리온 파마슈티칼 리미티드 3-(헤테로아릴-아미노)-1,2,3,4-테트라히드로-9h-카르바졸 유도체 및 이의 프로스타글란딘 d2 수용체 조절제로서의 용도
CA2795062A1 (en) 2010-04-02 2011-10-06 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
CA2909117A1 (en) * 2013-04-09 2014-10-16 Cresset Biomolecular Discovery Ltd The treatment of inflammatory disorders
AR119319A1 (es) 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida
CN112125836A (zh) * 2020-10-15 2020-12-25 濮阳惠成电子材料股份有限公司 有机电致光电材料中间体n-苯基咔唑-3-羧酸乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5-取代-3-(1,2,3,6-四氢吡啶-4-基)-和3-(哌啶-4-基)-1h-吲哚:新型5-ht1f激动剂
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles

Also Published As

Publication number Publication date
AU7795598A (en) 1998-12-21
NZ501569A (en) 2001-11-30
DE69814735T2 (de) 2004-03-25
TR199903014T2 (xx) 2000-05-22
DE69814735D1 (de) 2003-06-26
EA001718B1 (ru) 2001-08-27
HUP0004142A3 (en) 2002-10-28
ID23053A (id) 2000-01-20
JP2002502419A (ja) 2002-01-22
PL337221A1 (en) 2000-08-14
ATE240953T1 (de) 2003-06-15
NO995963L (no) 1999-12-03
EP0882726A1 (en) 1998-12-09
PT882726E (pt) 2003-09-30
CN1259049A (zh) 2000-07-05
ES2199410T3 (es) 2004-02-16
NO995963D0 (no) 1999-12-03
AU729786B2 (en) 2001-02-08
IL133279A0 (en) 2001-04-30
HUP0004142A2 (hu) 2001-05-28
EP0882726B1 (en) 2003-05-21
WO1998055115A1 (en) 1998-12-10
BR9810610A (pt) 2000-09-12
CA2291624A1 (en) 1998-12-10
EA199901113A1 (ru) 2000-08-28
KR20010013409A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
ATE253063T1 (de) 5-ht1f-agonisten
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
DK0882726T3 (da) Carbazolcarboxamider som 5-HT1F-agonister
CA2354023A1 (en) Phenylglycine derivatives
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
GB9801690D0 (en) Therapeutic agents
BR9808491A (pt) Compostos calcilìticos
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ATE126509T1 (de) Disäuren von diarylstyrylchinolin.
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
DK0810220T3 (da) Arylacrylamidderivater som 5-HT1-agonister eller -antagonister
PT1204659E (pt) Benzofuranos serotoninergicos
NO20002408D0 (no) 5-HT1F antagonister
BR9902096A (pt) Pitazóis.
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya